Friday, 24 April 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny
4 Mar, 07:30 — 4 Mar, 07:30
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
51d ago
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny
Read full article →
Something wrong with this story? Report an issue
Related Stories
Dangerous Heat Index Forecast for Cotabato City and Cavite City
just now
El Niño Causes Water Supply Decline in Butuan City
just now
Bohol Implements El Niño Preparedness Measures
just now
Metro Cebu Air Quality Improves, Haze Alert Downgraded
just now
Friday, 24 April 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
